Study on bringing AMR medical countermeasures to the market

This report focuses upon the prospective roles and responsibilities of the European Union (EU); specifically in supporting new developments in the pipeline and ensuring access to Antimicrobial Resistance (AMR) Medical Countermeasures (MCMs) brought to market. Survey respondents:
- expect DG HERA to play an important role in the implementation of a new pull mechanism;
- expect DG HERA to contribute or complement existing financial push incentives; and
- noted that DG HERA could assist with the provision of non-financial support, including knowledge sharing, dissemination of best practices and capacity building for Member States.